망막하신생혈관이 동반된 양측 후천성 중심와부근 모세혈관 확장증에서의 복합치료 1예

• 영문명: A Case of Combination Therapy for Subretinal Neovascularization in Bilateral Acquired Parafoveal Telangiectasis
• 발행기관: 대한안과학회
• 저자명: 류정완 김재련 이원기,Jeong-Wan Ryu, MD, Jae-Ryun Kim, MD, Won-Ki Lee, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume50,number9, 1423~1426쪽, 전체 4쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2009.09.15

영문 초록

Purpose: To evaluate the clinical results of a case of subretinal neovascularization (SRN) in bilateral acquired parafoveal telangiectasis, performed combination therapy of intravitreal bevacizumab (1.25 mg/0.05ml) and photodynamic therapy (PDT). Case summary: A 46-year-old female presented with a decrease invisual acuity. Her best-corrected visual acuity (BCVA) was 1.0 in the right eye and 0.1 in the left eye. On ophthalmic examination, she was diagnosed with bilateral acquired parafoveal telangiectasis combined with SRN in the left eye. Intravitreal bevacizumab was injected, and then photodynamic therapy was performed 4 days later. Three months after the combination therapy, her BCVA improved to 0.5, a regression of SRN was observed and vascular leakage was markedly decreased. However, her BCVA decreased to 0.1 and SRN recurred 9 months later. Conclusions: The combined treatment of intravitreal bevacizumab and photodynamic therapy may be used as a selective alternative treatment modality for SRN in bilateral acquired parafoveal telangiectasis, although its effect is short-term.

키워드

Bevacizumab, Bilateral acquired parafoveal telangiectasis, Combination therapy, Photodynamic therapy, Subretinal neovascularization